Today, several immunological rapid tests are on the way to the Norwegian market. Manufacturers have limited documentation on the quality of these tests.
By conducting a limited and rapid assay, we will be able to elucidate first and foremost the sensitivity of the COVID-19 IgG and -IgM tests compared to the COVID-19 PCR.
Secondly, we will investigate the time span from infection to the rapid tests can be expected to be positive. We will also gain experience with how the tests work under Norwegian conditions. This is necessary in order to give good advice on how fast tests should be used and how they should not be used.